Treatment of skin and soft tissue infections with oral ciprofloxacin
- PMID: 3804903
- DOI: 10.1093/jac/18.supplement_d.153
Treatment of skin and soft tissue infections with oral ciprofloxacin
Abstract
Thirty adult patients with severe skin and soft tissue infections (four with contiguous osteomyelitis) caused by a variety of bacterial pathogens were treated with oral ciprofloxacin. Favourable clinical responses were observed in 23 (92%) of the 25 evaluable cases. All Enterobacteriaceae and anaerobic bacteria were eradicated during treatment. Enterococci, Staphylococcus aureus, and Pseudomonas aeruginosa were usually eradicated but occasional strains persisted during treatment. Strains that persisted during treatment were associated with therapeutic failure in two cases, one with contiguous osteomyelitis and one with vascular gangrene. The only significant adverse reaction observed was nausea and/or vomiting in five of the 30 patients.
Similar articles
-
Ciprofloxacin for soft tissue infections.J Antimicrob Chemother. 1986 Nov;18 Suppl D:159-64. doi: 10.1093/jac/18.supplement_d.159. J Antimicrob Chemother. 1986. PMID: 3804904
-
Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.Antimicrob Agents Chemother. 1987 Feb;31(2):151-5. doi: 10.1128/AAC.31.2.151. Antimicrob Agents Chemother. 1987. PMID: 3566245 Free PMC article.
-
Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections.Am J Med. 1985 Nov 29;79(5B):141-5. doi: 10.1016/0002-9343(85)90148-2. Am J Med. 1985. PMID: 4073082 Clinical Trial.
-
Ticarcillin-clavulanate therapy for bacterial skin and soft tissue infections.Rev Infect Dis. 1991 Jul-Aug;13 Suppl 9:S733-6. doi: 10.1093/clinids/13.supplement_9.s733. Rev Infect Dis. 1991. PMID: 1925317 Review.
-
Ciprofloxacin in the treatment of acute and chronic osteomyelitis: a review.Scand J Infect Dis Suppl. 1989;60:74-8. Scand J Infect Dis Suppl. 1989. PMID: 2667110 Review.
Cited by
-
Ciprofloxacin release using natural rubber latex membranes as carrier.Int J Biomater. 2014;2014:157952. doi: 10.1155/2014/157952. Epub 2014 Dec 22. Int J Biomater. 2014. PMID: 25587278 Free PMC article.
-
Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.Drugs. 1988 Aug;36(2):193-228. doi: 10.2165/00003495-198836020-00004. Drugs. 1988. PMID: 3053126 Review.
-
Fluoroquinolone antimicrobial agents.Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378. Clin Microbiol Rev. 1989. PMID: 2680058 Free PMC article. Review.
-
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003. Drugs. 1988. PMID: 3292209 Review.
-
Comparative in vitro activities of sparfloxacin (CI-978; AT-4140) and other antimicrobial agents against staphylococci, enterococci, and respiratory tract pathogens.Antimicrob Agents Chemother. 1990 Nov;34(11):2283-6. doi: 10.1128/AAC.34.11.2283. Antimicrob Agents Chemother. 1990. PMID: 2127351 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical